全文获取类型
收费全文 | 3078篇 |
免费 | 179篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 60篇 |
妇产科学 | 26篇 |
基础医学 | 368篇 |
口腔科学 | 82篇 |
临床医学 | 254篇 |
内科学 | 758篇 |
皮肤病学 | 46篇 |
神经病学 | 127篇 |
特种医学 | 105篇 |
外科学 | 606篇 |
综合类 | 60篇 |
一般理论 | 3篇 |
预防医学 | 169篇 |
眼科学 | 81篇 |
药学 | 222篇 |
中国医学 | 20篇 |
肿瘤学 | 281篇 |
出版年
2024年 | 5篇 |
2023年 | 30篇 |
2022年 | 101篇 |
2021年 | 130篇 |
2020年 | 86篇 |
2019年 | 108篇 |
2018年 | 112篇 |
2017年 | 85篇 |
2016年 | 79篇 |
2015年 | 111篇 |
2014年 | 125篇 |
2013年 | 136篇 |
2012年 | 229篇 |
2011年 | 279篇 |
2010年 | 112篇 |
2009年 | 105篇 |
2008年 | 183篇 |
2007年 | 189篇 |
2006年 | 184篇 |
2005年 | 172篇 |
2004年 | 122篇 |
2003年 | 118篇 |
2002年 | 95篇 |
2001年 | 37篇 |
2000年 | 46篇 |
1999年 | 49篇 |
1998年 | 12篇 |
1997年 | 12篇 |
1996年 | 12篇 |
1995年 | 8篇 |
1994年 | 12篇 |
1993年 | 11篇 |
1992年 | 22篇 |
1991年 | 23篇 |
1990年 | 17篇 |
1989年 | 16篇 |
1988年 | 12篇 |
1987年 | 25篇 |
1986年 | 12篇 |
1985年 | 19篇 |
1984年 | 9篇 |
1979年 | 7篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1971年 | 2篇 |
1969年 | 3篇 |
1967年 | 2篇 |
排序方式: 共有3289条查询结果,搜索用时 15 毫秒
31.
Khalil Ullah Shahid Raza Parvez Ahmed Qamar-Un-Nisa Chaudhry Tariq Mahmood Satti Suhaib Ahmed Sajjad Hussain Mirza Fahim Akhtar Khalid Kamal Farrukh Mahmood Akhtar 《International journal of infectious diseases》2008,12(2):203-214
OBJECTIVE: To describe our experience of post-transplant infections in allogeneic stem cell transplants at the Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan. METHODS: From July 2001 to September 2006, patients with malignant and non-malignant hematological disorders having human leukocyte antigen (HLA)-matched sibling donors were selected for transplant. Pre-transplant infection surveillance was carried out, and strict prophylaxis against infection was observed. After admission to the hospital, patients were kept in protective isolation rooms, equipped with a HEPA filter positive-pressure laminar airflow ventilation system. Bone marrow and/or peripheral blood stem cells were used as the stem cell source. Cyclosporin and prednisolone were used as prophylaxis against graft-versus-host disease (GVHD). The engraftment was monitored with cytogenetic/molecular analysis and change of blood group. Survival was calculated from the date of transplant to death or last follow-up. RESULTS: One hundred and fifty-four patients received allogeneic stem cell transplants from HLA-matched siblings for various hematological disorders at the Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan between July 2001 and September 2006. Indications for transplant included aplastic anemia (n=66), beta-thalassemia major (n=40), chronic myeloid leukemia (n=33), acute leukemia (n=8), and miscellaneous disorders (n=7). One hundred and twenty patients were male and 34 were female. The median age of the patient cohort was 14 years (range 1 1/4-54 years). One hundred and thirty-six patients and 135 donors were cytomegalovirus (CMV) IgG-positive. One hundred and forty patients (90.9%) developed febrile episodes in different phases of post-transplant recovery. Infective organisms were isolated in 150 microbiological culture specimens out of 651 specimens from different sites of infections (23.0% culture positivity). Post-transplant infections were confirmed in 120 patients (77.9%) on the basis of clinical assessment and microbiological, virological, and histopathological examination. Mortality related to infections was 13.0%. Fatal infections included CMV disease (100% mortality, 6/6), disseminated aspergillosis (66.7% mortality, 4/6), pseudomonas septicemia (42.9% mortality, 9/21), and tuberculosis (25% mortality, 1/4). CONCLUSIONS: More than 90% of our patients developed febrile episodes with relatively low culture yield. The majority of infections were treated effectively, however CMV, aspergillosis, and pseudomonas infections remained problematic with high mortality. 相似文献
32.
Abdul Wadood Khan Sabna Kotta Shahid Husain Ansari Rakesh Kumar Sharma 《Drug delivery》2015,22(4):552-561
AbstractNaringenin (NRG), predominant flavanone in grapefruits, possesses anti-inflammatory, anti-carcinogenic, hepato-protective and anti-lipid peroxidation effects. Slow dissolution after oral ingestion due to its poor solubility in water, as well as low bioavailability following oral administration, restricts its therapeutic application. The study is an attempt to improve the solubility and bioavailability of NRG by employing self-nanoemulsifying drug delivery technique. Preliminary screening was carried out to select oil, surfactant and co-surfactant, based on solubilization and emulsification efficiency of the components. Pseudo ternary phase diagrams were constructed to identify the area of nanoemulsification. The developed self-nanoemulsifying drug delivery systems (SNEDDS) were evaluated in term of goluble size, globule size distribution, zeta potential, and surface morphology of nanoemulsions so obtained. The TEM analysis proves that nanoemulsion shows a droplet size less than 50?nm. Freeze thaw cycling and centrifugation studies were carried out to confirm the stability of the developed SNEDDS. In vitro drug release from SNEDDS was significantly higher (p?<?0.005) than pure drug. Furthermore, area under the drug concentration time-curve (AUC0–24) of NRG from SNEDDS formulation revealed a significant increase (p?<?0.005) in NRG absorption compared to NRG alone. The increase in drug release and bioavailability as compared to drug suspension from SNEDDS formulation may be attributed to the nanosized droplets and enhanced solubility of NRG in the SNEDDS. 相似文献
33.
Ahmed S Siddiqui AK Siddiqui RK Kimpo M Russo L Mattana J 《American journal of hematology》2003,73(3):190-193
Sickle cell disease is characterized by chronic hemolytic anemia and vaso-occlusive painful crisis. The vascular occlusion in sickle cell disease is a complex process and accounts for the majority of the clinical manifestations of the disease. Abdominal pain is an important component of vaso-occlusive painful crisis and may mimic diseases such as acute appendicitis and cholecystitis. Acute pancreatitis is rarely included as a cause of abdominal pain in patients with sickle cell disease. When it occurs it may result form biliary obstruction, but in other instances it might be a consequence of microvessel occlusion causing ischemia. In this series we describe four cases of acute pancreatitis in patients with sickle cell disease apparently due to microvascular occlusion and ischemic injury to the pancreas. All patients responded to conservative management. Acute pancreatitis should be considered in the differential diagnosis of abdominal pain in patients with sickle cell disease. 相似文献
34.
Smetana Keaton S. Zakeri Amanda Dolia Jaydevsinh Huttinger Allyson May Casey C. Youssef Patrick Gross Bradley A. Nimjee Shahid M. 《Journal of thrombosis and thrombolysis》2021,52(4):1182-1186
Journal of Thrombosis and Thrombolysis - Tandem occlusions exist in 17–32% of large vessel occlusion (LVO) strokes. A significant concern is bleeding when carotid stenting is performed in... 相似文献
35.
Sperry Brett W. Khoury Julie A. Raza Shahzad Rosenthal Julie L. 《Heart failure reviews》2022,27(5):1559-1565
Heart Failure Reviews - Amyloidosis is a multisystem disease which continues to present in later stages due to delayed diagnosis. Once the disease is identified, the coordination of ongoing care... 相似文献
36.
Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. 总被引:4,自引:0,他引:4
Raza Alikhan Alexander T Cohen Sophie Combe Meyer M Samama Louis Desjardins Amiram Eldor Charles Janbon Alain Leizorovicz Carl-Gustav Olsson Alexander G G Turpie 《Blood coagulation & fibrinolysis》2003,14(4):341-346
The Medical Patients with Enoxaparin (MEDENOX) trial was a randomized, placebo-controlled study that defined the risk of venous thromboembolism (VTE) in acutely ill, immobilized, general medical patients and the efficacy of the low-molecular-weight heparin, enoxaparin, in preventing thrombosis. We performed a post-hoc analysis to evaluate the effect of 40 mg enoxaparin once daily on MEDENOX patient outcome in different types of acute medical illness (heart failure, respiratory failure, infection, rheumatic disorder and inflammatory bowel disease) and pre-defined risk factors (chronic heart and chronic respiratory failure, age, immobility, previous VTE and cancer). The primary outcome was the occurrence of documented VTE between days 1 and 14. The relative risk reduction [95% confidence intervals (CI)] for VTE comparing 40 mg enoxaparin with placebo in the subgroups were: acute heart failure, 0.29 (95% CI, 0.10-0.84); acute respiratory failure, 0.25 (95% CI, 0.10-0.65); acute infectious disease, 0.28 (95% CI, 0.09-0.81); and acute rheumatic disorder, 0.48 (95% CI, 0.11-2.16). The relative risk reduction for VTE in the pre-defined risk factor subgroups were: chronic heart failure, 0.26 (95% CI, 0.08-0.92); chronic respiratory failure, 0.26 (95% CI, 0.10-0.68); age, 0.22 (95% CI, 0.09-0.51); immobility, 0.53 (95% CI, 0.14-1.72); previous VTE, 0.49 (95% CI, 0.15-1.68); and cancer, 0.50 (95%o CI, 0.14-1.72). The beneficial effects of enoxaparin extend to a wide range of acutely ill medical patients. 相似文献
37.
Lim M Gonsalves S Thekkinkattil D Seedat S Finan P Sagar P Burke D 《Diseases of the colon and rectum》2008,51(1):96-99
Purpose
Pouchitis is a common complication after ileal pouch-anal anastomosis. Diagnosis is based on the Pouch Disease Activity Index, which comprises clinical symptoms, endoscopic appearance, and histologic confirmation. A Pouch Disease Activity Index ≥ 7 confirms pouchitis. Fecal lactoferrin is a marker of intestinal inflammation, which can aid in the diagnosis of pouchitis. The IBD EZ VUE? test is a simple, rapid, noninvasive test for fecal lactoferrin. Our goal was to study the sensitivity and specificity of this test in the diagnosis of pouchitis.Methods
Consecutive patients with pouch dysfunction were recruited from October 2005 to July 2006. A fecal sample was collected before calculation of the Pouch Disease Activity Index. An IBD EZ VUE? test was performed on each fecal sample and the results correlated with the diagnosis of pouchitis to calculate sensitivity and specificity of the IBD EZ VUE? test.Results
There were 32 patients (21 healthy and 11 inflammed pouches). The IBD EZ VUE? test was positive in 14 patients. It had a sensitivity of 100 percent and a specificity of 86 percent in diagnosing pouchitis. The positive predictive value was 76 percent. There were three false-positive results.Conclusions
The IBD EZ VUE? test is a sensitive method that may remove the need for invasive pouch investigations and lead to greater confidence when antibiotic therapy is commenced. Further investigations may be reserved for those patients who have a positive lactoferrin test and fail to respond to antibiotic treatment. 相似文献38.
G. Browman H. Preisler A. Raza K. Syracuse N. Azarnia A. Benger P. Chervenick P. D''Arrigo T. Doeblin J. Goldberg A. Gottlieb H. Grunwald J. Kirshner R. Larson R. Meyer K. Miller R. Priore M. Stein W. R. Vogler I. Walker W. E. C. Wilson M. Barcos 《British journal of haematology》1989,71(4):493-497
Patients with acute myeloid leukaemia who fail to show substantial bone marrow cytoreduction by day 6 of induction therapy enter complete remission (CR) less frequently than patients with good bone marrow leukaemic cytoreduction. The objective of the current study was to determine whether an increase in the intensity of therapy on days 8, 9 and 10 ('augmentation' of remission induction therapy) for patients with poor bone marrow cytoreduction detected in the day 6 bone marrow could improve the complete remission rate without increasing the number of toxic deaths. Patients from six centres were entered and treated with standard dose ara-C for 7 or 10 d and an anthracycline for the first 3 d. Patients aged less than 60 years and with greater than 30% bone marrow biopsy cellularity or greater than 10% abnormal cells on the aspirate obtained 6 d after the start of therapy were augmented with cytosine arabinoside 3 g/m2 every 12 h on days 8, 9 and 10. Therapy was augmented in 116 of the 252 patients less than 60 years. There was a highly statistically significant difference between augmented and nonaugmented patients (P less than 0.001) for the per cent biopsy cellularity and per cent abnormal cells in the day 6 marrow. The CR rate for augmented patients was 69% and for nonaugmented patients 60% suggesting that augmentation therapy abrogated the prognostic significance of more extensive residual leukaemia in the day 6 bone marrow. The results suggest that augmentation of remission induction for patients with poor bone marrow cytoreduction detected 6 d after initiation of therapy, may salvage patients who are destined to fail remission induction because of resistant disease without producing excessive toxicity. 相似文献
39.
High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study 总被引:1,自引:0,他引:1
H D Preisler A Raza M Barcos N Azarnia R Larson G Browman I Walker H Grunwald P D'Arrigo A Stein 《American journal of hematology》1986,23(2):131-134
Fifteen patients with myelodysplastic/myeloproliferative disorders were treated with high-dose cytosine arabinoside therapy. While severe toxicity was produced in every patient, only two of the 15 patients entered complete remission and two achieved partial remission status. The therapeutic responses were confined to patients who had severe myelofibrosis of apparently recent onset. 相似文献
40.
Kathryn M. Day Rachel Pike Trevor G. Winstanley Clare Lanyon Stephen P. Cummings Muhammad W. Raza Neil Woodford John D. Perry 《Journal of clinical microbiology》2013,51(6):1881-1886
The aim of this study was to determine the ability of a disc susceptibility test using faropenem (10 μg) to predict carbapenemase activity in Enterobacteriaceae. A collection of 166 isolates of carbapenemase-producing Enterobacteriaceae (CPE) and 82 isolates of Enterobacteriaceae that produced other β-lactamases was compiled from diverse sources. Disc susceptibility testing was performed using the CLSI/EUCAST methodology with discs of faropenem (10 μg), temocillin (30 μg), and four carbapenems (each 10 μg). A further prospective evaluation of the faropenem disc susceptibility test was performed using 205 consecutive isolates referred to a United Kingdom reference laboratory in parallel with molecular methods for carbapenemase detection. Of 166 isolates of CPE, 99% showed growth up to the edge of a 10-μg faropenem disc compared with only 6% of other β-lactamase producers (sensitivity, 99%; specificity, 94%). A “double zone” around 10-μg faropenem discs was frequently associated with OXA-48 producers. Of the carbapenems, the most useful agent was imipenem, where a zone diameter of ≤23 mm as a predictor of carbapenemase activity had a sensitivity of 99% and a specificity of 85%. The presence of no zone of inhibition around a 30-μg temocillin disc was a consistent feature of strains producing OXA-48 carbapenemase. For 205 isolates of Enterobacteriaceae referred to a United Kingdom reference laboratory, growth up to a 10-μg faropenem disc correctly identified 84 of 86 carbapenemase producers (98% sensitivity), with a specificity of 87%. Disc susceptibility testing using faropenem (10 μg) is a simple, convenient, and highly predictive screening test for carbapenemase-producing Enterobacteriaceae. 相似文献